On December 5 from 4:00-5:00 PM ET, ASCO will host the latest installment in its webinar series on the 2019 Medicare Physician Fee Schedule (MPFS). This webinar, 2019 Medicare Reimbursement – Final Rules Update, comes as the Centers for Medicare & Medicaid Services (CMS) recently released its final rule outlining reimbursement changes to the MPFS, Quality Payment Program (QPP) and Hospital Outpatient Prospective Payment System (HOPPS) for 2019.
CMS estimates that the overall impact of the 2019 changes will be a one percent reimbursement cut for the hematology/oncology and radiation/oncology specialties. However, it is important to note that the actual impact on individual physician practices will depend on the mix of services the practice provides.
Among the changes for calendar year 2019, CMS finalized provisions from its proposed rule to reduce the documentation burden for Evaluation & Management (E&M) services and to reimburse new Medicare Part B drugs—and drugs that do not have a reported Average Sales Price (ASP)—at Wholesale Acquisition Cost (WAC) +3 percent. New Part B drugs are currently reimbursed at WAC +6 percent.
Registration is necessary to attend this webinar and participants can register here. Once registered, attendees will receive an email with a calendar invitation and call-in instructions.
Stay tuned to ASCO in Action for Medicare physician reimbursement updates and breaking cancer policy news.